The TGA, as part of the Australian Government Department of Health, is responsible for enabling therapeutic goods available for supply in Australia to be safe and fit for their intended purpose. These include goods Australians rely on every day, such as analgesics and sunscreens, through to goods used to treat and prevent serious conditions, such as prescription medicines, vaccines, blood products and surgical implants.
The TGA Business Plan provides details on our key deliverables in relation to the regulation of therapeutic goods, and should be read in concert with our performance reporting.
Contents
- Introduction
- Our vision
- Our Purpose
- Strategic framework
- Reporting
- Funding
- Our priorities for 2022-23
Print version
Download
TGA business plan 2022-23 as
PDF [562.2 KB]